Is technically complicated partial nephrectomy justified in renal cell carcinoma patients with normal contralateral kidney?

IF 0.1 Q4 ONCOLOGY
M. Volkova, V. A. Ridin, V. A. Cherniayev, A. Klimov, K. Figurin, A. Kirichek, V. Matveev
{"title":"Is technically complicated partial nephrectomy justified in renal cell carcinoma patients with normal contralateral kidney?","authors":"M. Volkova, V. A. Ridin, V. A. Cherniayev, A. Klimov, K. Figurin, A. Kirichek, V. Matveev","doi":"10.17650/1726-9776-2019-15-4-39-49","DOIUrl":null,"url":null,"abstract":"Objective: to compare the results of partial (PN) and radical nephrectomy (RN) in patients with renal parenchymal tumors with nephrometric PADUA index ≥8 and/or RENAL index ≥7 and functioning contralateral kidney.Materials and methods. Medical data of 114 consecutive patients with renal cell carcinoma (RCC) cT1–3aN0M0 and functioning contralateral kidney were included into the study: 57 (50.0 %) persons undergone PN for tumors with nephrometric PADUA index ≥8 and/or RENAL index ≥7 (the main group), and 57 (50.0 %) patients undergone RN (the control group). The groups were comparable with regards to demographic characteristics, nephrometric parameters, morphological tumor features, and baseline glomerular filtration rate (р >0.05 for all). Median follow-up – 52.0 ± 23.6 (9.1–138.5) months.Results. Technically complicated PNs were associated with an increase of median surgery time (by 39 min, р = 0.06), blood loss (by 319 ml, p within the groups. Chronic kidney disease (CKD) progression rate was significantly higher in RN than in PN group (40 % vs 31.6 % respectively, р = 0.050), including more frequent development of CKD stages III–IV (31.6 % vs 26.3 % respectively; р = 0.034). There was no difference of long-term survival between PN and RN groups, and that included survival results stratified according to gender, age, baseline CKD stage, PADUA and RENAL indexes. Five-year recurrence-free survival was 94.1 % vs 92.2 % (р = 0.223), cancer-specific survival – 92.3 % vs 90.8 % (р = 0.443), cardio-specific survival – 91.6 % vs 77.9 % (р = 0.549), overall survival – 89.8 % vs 70.7 % respectively (р = 0.858).Conclusion. PN is effective and safe method of treatment in patients with renal parenchymal tumors with PADUA index ≥8 and/or RENAL index ≥7 and functioning contralateral kidney, providing significant functional benefit without survival compromising when compared with RN.","PeriodicalId":42924,"journal":{"name":"Onkourologiya","volume":"1 1","pages":""},"PeriodicalIF":0.1000,"publicationDate":"2020-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Onkourologiya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/1726-9776-2019-15-4-39-49","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

Objective: to compare the results of partial (PN) and radical nephrectomy (RN) in patients with renal parenchymal tumors with nephrometric PADUA index ≥8 and/or RENAL index ≥7 and functioning contralateral kidney.Materials and methods. Medical data of 114 consecutive patients with renal cell carcinoma (RCC) cT1–3aN0M0 and functioning contralateral kidney were included into the study: 57 (50.0 %) persons undergone PN for tumors with nephrometric PADUA index ≥8 and/or RENAL index ≥7 (the main group), and 57 (50.0 %) patients undergone RN (the control group). The groups were comparable with regards to demographic characteristics, nephrometric parameters, morphological tumor features, and baseline glomerular filtration rate (р >0.05 for all). Median follow-up – 52.0 ± 23.6 (9.1–138.5) months.Results. Technically complicated PNs were associated with an increase of median surgery time (by 39 min, р = 0.06), blood loss (by 319 ml, p within the groups. Chronic kidney disease (CKD) progression rate was significantly higher in RN than in PN group (40 % vs 31.6 % respectively, р = 0.050), including more frequent development of CKD stages III–IV (31.6 % vs 26.3 % respectively; р = 0.034). There was no difference of long-term survival between PN and RN groups, and that included survival results stratified according to gender, age, baseline CKD stage, PADUA and RENAL indexes. Five-year recurrence-free survival was 94.1 % vs 92.2 % (р = 0.223), cancer-specific survival – 92.3 % vs 90.8 % (р = 0.443), cardio-specific survival – 91.6 % vs 77.9 % (р = 0.549), overall survival – 89.8 % vs 70.7 % respectively (р = 0.858).Conclusion. PN is effective and safe method of treatment in patients with renal parenchymal tumors with PADUA index ≥8 and/or RENAL index ≥7 and functioning contralateral kidney, providing significant functional benefit without survival compromising when compared with RN.
技术上复杂的部分肾切除术在对侧肾正常的肾细胞癌患者中是否合理?
目的:比较PADUA指数≥8和/或renal指数≥7且对侧肾脏功能正常的肾实质肿瘤患者部分肾切除术(PN)和根治性肾切除术(RN)的效果。材料和方法。研究纳入了114例连续的对侧肾功能正常的肾细胞癌(RCC) cT1-3aN0M0患者的医疗资料:57例(50.0%)因肾脏指标PADUA指数≥8和/或renal指数≥7的肿瘤接受PN治疗(主要组),57例(50.0%)接受RN治疗(对照组)。两组在人口学特征、肾指标、肿瘤形态学特征和基线肾小球滤过率方面具有可比性(所有组均为0.05)。中位随访- 52.0±23.6(9.1-138.5)个月。技术上复杂的PNs与组内中位手术时间(增加39分钟,p = 0.06)和出血量(增加319 ml, p)相关。慢性肾脏疾病(CKD)在RN组的进展率显著高于PN组(分别为40%和31.6%,r = 0.050),包括更频繁地发展为CKD III-IV期(分别为31.6%和26.3%;= 0.034)。PN组和RN组的长期生存无差异,包括根据性别、年龄、基线CKD分期、PADUA和RENAL指标进行分层的生存结果。5年无复发生存率为94.1% vs 92.2% (r = 0.223),癌症特异性生存率为92.3% vs 90.8% (r = 0.443),心脏特异性生存率为91.6% vs 77.9% (r = 0.549),总生存率为89.8% vs 70.7% (r = 0.858)。对于PADUA指数≥8和/或renal指数≥7且对侧肾脏功能正常的肾实质肿瘤患者,PN是一种有效且安全的治疗方法,与RN相比,PN可提供显着的功能获益而不影响生存。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Onkourologiya
Onkourologiya ONCOLOGY-
CiteScore
0.40
自引率
0.00%
发文量
59
审稿时长
10 weeks
期刊介绍: The main objective of the journal "Cancer urology" is publishing up-to-date information about scientific clinical researches, diagnostics, treatment of oncologic urological diseases. The aim of the edition is to inform the experts on oncologic urology about achievements in this area, to build understanding of the necessary integrated interdisciplinary approach in therapy, alongside with urologists, combining efforts of doctors of various specialties (cardiologists, pediatricians, chemotherapeutists et al.), to contribute to raising the effectiveness of oncologic patients’ treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信